Anson Group

By  Brian Dolan 03:39 am May 29, 2012
Photo Credit: Paul Savage Photography By Padma Nagappan One of the panels at the recently concluded WLSA Convergence Summit in San Diego focused on how things have changed within the last five years and whether the guidelines the FDA issued last year for devices helps provide clarity in navigating the choppy waters of clearance. The panel featured two companies that have received 510(k)...
By  Brian Dolan 08:51 am February 8, 2010
Strategies for mHealth Companies Wishing to Avoid FDA Regulation By Bradley Merrill Thompson (I would like to thank Leah Kendall of EpsteinBeckerGreen and Dane Stout of the Anson Group for their comments on a draft. The views expressed, right or wrong, are only the author’s and should not be attributed to anyone else.) Most people know the difference between tax avoidance and tax evasion. Tax...